|
|
| Research article summary (published 29 Jun 2006): |
Factor V Leiden mutation and pregnancy-related venous thromboembolism: what is the exact risk? Results from a meta-analysis.
Full Abstract
The magnitude of the association of factor V Leiden mutation with pregnancy-related venous thrombosis remains unclear. Our objective was to undertake a systematic review and a metaanalysis of the literature to estimate precisely the association of factorV Leiden mutation with the risk of first, or recurrent, pregnancy-related venous thromboembolism. Studies published before October 2005 were identified by Medline((R)). Using both fixed and random effect models, odds ratios (OR) with accompanying 95% confidential intervals (CI) were calculated for the factor V Leiden mutation and the clinical end-point (Yusuf-Peto adaptation of the Mantel-Haenszel, DerSimonian and Laird method). We identified 13 studies including 7 cohorts and 6 casecontrol studies relating to factor V Leiden and pregnancy-related venous thrombosis. The results from the cohorts showed a pooled OR of 4.46 (95% CI, 1.82-10.94; 7,879 pooled women), with no evidence of statistical heterogeneity (p = 0.36), for the risk of a first venous thromboembolism during pregnancy or the postpartum period associated with the factor V Leiden mutation. Case-control studies revealed a higher risk (OR 8.6, 95% CI, 5.85-12.63; 1,433 [corrected] pooled women) with significant heterogeneity (p < 0.005). Because of insufficient data, an analysis for the risk of recurrence could not be performed. Our findings emphasize the fact that limited data are available on this topic. This meta-analysis provides clinicians with an estimate of the average risk of a first thrombosis occurring during pregnancy in women carrying the factor V Leiden to assist the management of such women.
Learn Faster Today Improve your study skills
Author information
Author/s: Biron-Andreani, Christine (C); Schved, Jean-Francois (JF); Daures, Jean-Pierre (JP);
Affiliation: Hopital Saint-Eloi, Laboratoire d' Hematologie, Montpellier, France. c-biron(-atsign-)chu-montpellier.fr
Journal and publication information
Publication Type: Journal Article; Meta-Analysis
Journal: Thrombosis and haemostasis (Thromb Haemost), published in Germany. (Language: eng)
Reference: 2006-Jul; vol 96 (issue 1) : pp 14-8
Dates: Created 2006/06/29; Completed 2006/10/30; Revised 2006/10/31;
PMID: 16807645, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
ErratumIn: Thromb Haemost. 2006 Sep;96(3):389.
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
Related articles
These are the highest related articles currently in the database:
- The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
30 Jan 2000 - Are factor V Leiden carriers who use oral contraceptives at extreme risk for venous thromboembolism?
30 May 2000 - The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study.
30 Dec 2002 - Factor V Leiden: a review of the literature.
29 Jun 2003 - Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
26 Nov 2006 - Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.
27 Feb 1999 - Factor V Leiden and prothrombin G20210A variant are risk factors for venous thromboembolism in the Argentinean population.
28 Feb 2000 - Venous thrombotic risk in family members of unselected individuals with factor V Leiden.
30 May 2000 - The relationship between the tissue plasminogen activator Alu I/D polymorphism and venous thromboembolism during pregnancy.
30 Mar 2001 - Factor V Leiden mutation and the risk of venous thromboembolism in pregnant women.
29 Nov 2001
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.